CEO and owner of Labmagister Ltd. The main profile of the company is organising hands-on laboratory trainings on life sciences and doing expert based CRO activities on drug discovery and development.Former profile at Sanofi Co. Ltd: As a well-qualified pharmacologist leader on pulmonary (COPD and asthma) indications with a sound record of achievement in building value through expertise in: » Drug discovery project management and leadership. » Program and organizational R&D management on COPD, asthma and chronic inflammation disease indications.» Strategic planning and performance metrics on drug discovery. » Applying Systems Biology and Systems Pharmacology tools and considerations.» Sharing vision, bridging functions and utilizing local synergisms. » Developing and applying discovery quality rulesI am proud of that I set up the Respiratory Pharmacology unit of Sanofi-Synthelabo from the scratch and some years later the preclinical development of small molecular weight new-chemical-entities for COPD and allergic asthma indication has been started based on the pharmacological proofs provided by my experimental pharmacology unit with my leadership.-Spin-off activity: Sanofi assigned the IP rights of “Theobromine antitussive compositions” (CN 1251039, EP 0969843 A2, JP 2001-518928 A, CA 2284774 C, EP 0969843 B1, US 6348470) to the inventors (including me). I managed the pre-clinical and clinical development up to the end of Phase I clinical trial by the financial support of a venture capitalist. After a successful Phase I clinical trial the IP rights were assigned to Ahn-Gook Pharm Company LTD. . They continued (are continuing) the clinical development. Theobromine is now available in Far East countries as an anti-tussive drug (Anycough TM).Publication: Theobromine inhibits sensory nerve activation and cough. FASEB J. 2005 Feb;19(2):231-3.

Working as a mentor for supporting young and innovative legal entities

Technical Experts are responsible for the assessment of project applications submitted under the Eurostars Programme.

External Quality Control Assurance expert at QualiCont In Vitro Diagnostic Quality ControlNonprofit Public Utility Ltd. Szeged, Hungary http://www.qualicont.com/index_en.html

Head of Experimental Pharmacology Department (4-6 PhD scientists and 7-8 research assistants)Co-chair (from 01.03.2004) of the Global Pharmacology group of Sanofi Internal Medicine Unit (Budapest group+ 40 overseas scientists) Board membership of the Sanofi Internal Medicine Unit International Leadership Team (decision making body)International Discovery Project Team Leader of a successful preclinical scientific program linked to orphan receptor research

Main activities and responsibilities Histology (mainly cardiac), organ bath technincs (vessel, heart, gut, tracheal), in vivo cardiovascular pharmacology, in vitro cardiac micro electrophysiology, inflammation pharmacology